Status:
UNKNOWN
MUltimodal Targeted Axillary Surgery
Lead Sponsor:
Parc de Salut Mar
Collaborating Sponsors:
GEICAM
Conditions:
Node-positive Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The present trial will prospectively evaluate the accuracy of both a systematic predefined axillary ultrasound imaging together with tumor load quantification of suspicious and sentinel axillary lymph...
Detailed Description
Axillary node clearance (ANC) is a controversial intervention in the surgical treatment of breast cancer. Different studies have shown that in some patients with infiltrated axillary lymph nodes but l...
Eligibility Criteria
Inclusion
- Node-positive breast cancer patients confirmed by biopsy or cytology
- Positivity confirmed before the surgical treatment
Exclusion
- Inability to confirm positive lymph nodes by biopsy or cytology
- Inability to understand the protocol design
- Poor understanding of the Spanish language
Key Trial Info
Start Date :
October 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04039893
Start Date
October 23 2019
End Date
November 15 2022
Last Update
October 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Mar
Barcelona, Spain, 08003